These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38225680)

  • 1. Self-expanding versus balloon expandable stent for intracranial arterial stenosis: A systematic review and meta-analysis.
    Qureshi AI; Lodhi A; Ma X; Ahmed R; Kwok CS; Maqsood H; Liaqat J; Hassan AE; Siddiq F; Gomez CR; Suri MFK
    J Neuroimaging; 2024; 34(3):295-307. PubMed ID: 38225680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial stenting for severe symptomatic stenosis: self-expandable versus balloon-expandable stents.
    Park S; Kim JH; Kwak JK; Baek HJ; Kim BH; Lee DG; Lee DH; Kim JS; Suh DC
    Interv Neuroradiol; 2013 Sep; 19(3):276-82. PubMed ID: 24070075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of self-expanding stents with distal embolic protection to balloon-expandable stents without a protection device in the treatment of symptomatic vertebral artery origin stenosis: a prospective randomized trial.
    Geng X; Hussain M; Du H; Zhao L; Chen J; Su W; Ma L; Gao Z; Ding Y; Ji X
    J Endovasc Ther; 2015 Jun; 22(3):436-44. PubMed ID: 25862360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon-mounting stent for intracranial arterial stenosis: A comprehensive and comparative systematic review and meta-analysis.
    Abdollahifard S; Yousefi O; Kamran H; Mowla A
    Interv Neuroradiol; 2023 Aug; 29(4):466-480. PubMed ID: 35549530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular treatment of symptomatic intracranial arterial stenosis: six-year experience in a single-center series of 42 consecutive patients with acute and mid-term results.
    Costalat V; Maldonado IL; Zerlauth JB; Menjot N; Riquelme C; Machi P; Vendrell JF; Bonafé A
    Neurosurgery; 2010 Dec; 67(6):1505-13; discussion 1513-4. PubMed ID: 21107181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balloon-mounting stent versus balloon angioplasty for intracranial arterial stenosis: A systematic review and meta-analysis.
    Musmar B; Salim H; Abdelgadir J; Spellicy S; Adeeb N; Liu J; Jabbour P; Hasan D; Zomorodi A
    J Stroke Cerebrovasc Dis; 2024 May; 33(5):107631. PubMed ID: 38331010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications and long-term in-stent restenosis of endovascular treatment of severe symptomatic intracranial atherosclerotic stenosis and relevant risk factors.
    Yang L; Du H; Zhang D; Qiao Z; Su X; Han S; Gao BL; Cao Q
    Medicine (Baltimore); 2023 Sep; 102(38):e34697. PubMed ID: 37747021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elective treatment of intracranial stenosis with the balloon-expandable Pharos Vitesse stent: 30-day stroke rate and complications.
    von Schoenfeldt P; Krützelmann A; Bußmeyer M; Mpotsaris A; Rosenkranz M; Fiehler J; Weber W; Buhk JH
    J Neurointerv Surg; 2015 Mar; 7(3):188-93. PubMed ID: 24510379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis.
    Wang T; Luo J; Wang X; Yang K; Jadhav V; Gao P; Ma Y; Zhao N; Jiao L
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013267. PubMed ID: 32789891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balloon-expandable stents for treatment of symptomatic middle cerebral artery stenosis: Clinical outcomes during long-term follow-up.
    Baik SH; Kwak HS; Chung GH; Hwang SB
    Interv Neuroradiol; 2018 Dec; 24(6):666-673. PubMed ID: 29991311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.
    Zaidat OO; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Megerian JT; Lesko J; Pitzer P; Ramos J; Castonguay AC; Barnwell S; Smith WS; Gress DR;
    JAMA; 2015 Mar 24-31; 313(12):1240-8. PubMed ID: 25803346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balloon-mounted versus self-expanding stents for symptomatic intracranial vertebrobasilar artery stenosis combined with poor collaterals.
    Zhang Y; Rajah GB; Liu P; Sun Y; Liu T; Li X; Miao Z; Li G
    Neurol Res; 2019 Aug; 41(8):704-713. PubMed ID: 31030623
    [No Abstract]   [Full Text] [Related]  

  • 15. Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses : analysis of the INTRASTENT multicentric registry.
    Kurre W; Brassel F; Brüning R; Buhk J; Eckert B; Horner S; Knauth M; Liebig T; Maskova J; Mucha D; Sychra V; Sitzer M; Sonnberger M; Tietke M; Trenkler J; Turowski B; Berkefeld J;
    Neuroradiology; 2012 Jan; 54(1):43-50. PubMed ID: 21221557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term outcome of stenting with Enterprise stents for symptomatic intracranial atherosclerotic disease at a single center.
    Li A; Ye Z; Zhou W; Qin C
    Interv Neuroradiol; 2023 Dec; 29(6):731-737. PubMed ID: 36259331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
    Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B
    Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharos neurovascular intracranial stent: elective use for a symptomatic stenosis refractory to medical therapy.
    Mocco J; Darkhabani Z; Levy EI
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):642-6. PubMed ID: 19496116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter analysis of stenting in symptomatic intracranial atherosclerosis.
    Jiang WJ; Cheng-Ching E; Abou-Chebl A; Zaidat OO; Jovin TG; Kalia J; Hussain MS; Lin R; Malik AM; Hui F; Gupta R
    Neurosurgery; 2012 Jan; 70(1):25-30; discussion 31. PubMed ID: 21795866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Hussein HM; El-Gengaihy A; Abdelmoula M; K Suri MF
    Neurosurgery; 2008 May; 62(5):1053-60; discussion 1060-2. PubMed ID: 18580803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.